NYSE | ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index.
The underlying index is composed of common stocks of 30U. S. pharmaceutical companies.
These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 5.41% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.41% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 5.37% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 5.27% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 5.15% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 5.09% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 5.08% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 4.95% |
| BHC | Bausch Health Companies Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.90% |
| TARO | Taro Pharmaceutical Industries Ltd | Healthcare | Drug Manufacturers - Specialty & Generic | 3.59% |
| CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 3.57% |
| AVDL | Avadel Pharmaceuticals PLC | Healthcare | Drug Manufacturers - Specialty & Generic | 3.39% |
| HRMY | Harmony Biosciences Holdings | Healthcare | Biotechnology | 3.16% |
| OCUL | Ocular Therapeutix Inc | Healthcare | Biotechnology | 3.06% |
| AMRX | Amneal Pharmaceuticals, Inc. Class A Common Stock | Healthcare | Drug Manufacturers - Specialty & Generic | 3.05% |
| TVTX | Travere Therapeutics Inc | Healthcare | Biotechnology | 3.00% |
| LQDA | Liquidia Technologies Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.00% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.93% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 2.91% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 2.89% |